Sun Pharma acquires Japan's Pola Pharma

Sun Pharmaceutical, recently announced that it has entered into a definitive agreement to acquire Pola Pharma Inc. (&ldq...

November 29, 2018 | Thursday | News
AminoIndex risk screening: Catching cancer before it starts

Singapore - The fact that Japanese people have the longest lifespan in the world—and that they live healthier well...

November 29, 2018 | Thursday | News
Ono files for approval of ONO-7643 in Japan

Ono Pharmaceutical  announced today that ONO has submitted in Japan an application for manufacturing and marketing ...

November 28, 2018 | Wednesday | News
Daiichi Sankyo launches Trastuzumab Biosimilar in Japan

Daiichi Sankyo Company, Limited has launched the antitumor agent trastuzumab Biosimilar for intravenous drip infusions 6...

November 28, 2018 | Wednesday | News
Sysmex, MolecularMD commence global partnership

Sysmex Corporation, a Japanese in vitro diagnostics company, and MolecularMD Corporation, a US based molecular diagnosti...

November 28, 2018 | Wednesday | News
EC Approves Takeda’s ALUNBRIG for ALK+ Non-Small Cell Lung Cancer

Takeda Pharmaceutical Company Limited announced that the European Commission (EC) granted marketing authorization for AL...

November 28, 2018 | Wednesday | News
Eisai to present new research on Eribulin at SABC Symposium

Eisai Co., Ltd. has announced that the latest information on its in-house discovered and developed anticancer agent erib...

November 27, 2018 | Tuesday | News
Mitsui invests in Indian healthcare platform biz

Mitsui & Co. ("Mitsui") on November 21, 2018, acquired a stake in GOQii Inc. ("GOQii"), a business providing a preve...

November 26, 2018 | Monday | News
Japan Govt. takes lead to collaborate Japanese Healthcare with Germany

As the world's third largest economy, Japan is leading the way for aging societies. Therefore, the Government ...

November 23, 2018 | Friday | News
Eisai to present latest data on Perampanel at AES annual meeting

Eisai Co., Ltd. announced that the latest data on its antiepileptic drug (AED) perampanel (product name: Fycompa) will b...

November 23, 2018 | Friday | News
Takeda receives clearance from EC for proposed acquisition of Shire

Takeda has announced that it has received clearance from the European Commission for the proposed acquisition of Shire a...

November 22, 2018 | Thursday | News
Alvotech, Fuji Pharma partner for biosimilars

Alvotech and Fuji Pharma has announced that the two companies are entering into an exclusive partnership for the commerc...

November 20, 2018 | Tuesday | News
Mundipharma to bring world's first gene therapy for knee osteoarthritis

In a multi-year agreement for up to USD 600 million, Mundipharma has acquired the exclusive rights for Invossa in Japan ...

November 19, 2018 | Monday | News
Karl Deisseroth receives Japan’s Kyoto prize in advanced technology

The Inamori Foundation has announced that it has presented its 34th annual Kyoto Prize in Advanced Technology to Dr. Kar...

November 19, 2018 | Monday | News
HeartFlow receives reimbursement approval in Japan

HeartFlow, Inc. has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the recommenda...

November 19, 2018 | Monday | News
Takeda sets target date to close $62B Shire deal

Singapore – Aiming to close its deal for Shire on Jan. 8, Japanese drugmaker, Takeda Pharmaceutical will ...

November 12, 2018 | Monday | News
Philips, Allm to develop mobile diagnostic solutions

Royal Philips, a global leader in health technology, has announced a collaboration with Japanese healthcare informatics ...

November 12, 2018 | Monday | News
Japan conducts world’s first iPS cell transplant for Parkinson’s

A research team from Kyoto University, Japan has conducted the world’s first transplant of induced pluripotent ste...

November 10, 2018 | Saturday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls